20/20 Biolabs, Inc. (AIDX) stock
AIDXNasdaqServices-Testing LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 6/3059% below fair value
$0.20−0.02 (-9.38%)
Close on Nov 12, 2026Market cap $2.60MP/E –Yield –
20/20 Biolabs enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
20/20 Biolabs's enterprise value was -$1.79M on Nov 11, 2026.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$1.79M | – |
See a number that looks wrong?